Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation

Autoři: Ana Carolina Pires de Rezende aff001;  Eduardo Weltman aff001;  Michael Jenwei Chen aff003;  Juliana Karassawa Helito aff001;  Ícaro Thiago de Carvalho aff001;  Roberto Kenji Sakuraba aff001;  Nasjla Saba Silva aff004;  Andrea Maria Cappellano aff004;  Nelson Hamerschlak aff005
Působiště autorů: Department of Radiation Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil aff001;  Department of Radiation Oncology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil aff002;  Department of Radiation Oncology, Instituto de Oncologia Pediátrica - Grupo de Apoio ao Adolescente e à Criança com Câncer (GRAACC) da Universidade Federal de São Paulo, Sao Paulo, Brazil aff003;  Department of Pediatric Oncology, Instituto de Oncologia Pediátrica - Grupo de Apoio ao Adolescente e à Criança com Câncer (GRAACC) da Universidade Federal de São Paulo, São Paulo, Brazil aff004;  Department of Hematology and Clinical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil aff005
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article


Background and purpose

The roles of surgery, chemotherapy, and parameters of radiation therapy for treating very rare central nervous system germ cell tumors (CNS-GCT) are still under discussion. We aimed to evaluate the survival and recurrence patterns of patients with CNS-GCT treated with chemotherapy followed by whole ventricle irradiation with intensity-modulated radiation therapy.

Materials and methods

We reviewed the clinical outcomes of 20 consecutive patients with CNS-GCT treated with chemotherapy and intensity-modulated radiation therapy from 2004 to 2014 in two partner institutions.


Twenty children with a median age of 12 years were included (16 males). Sixteen tumors were pure germinomas, and 4 were non-germinomatous germ cell tumors (NGGCT). All patients were treated with intensity-modulated radiation therapy guided by daily images, and 70% with volumetric intensity-modulated arc radiotherapy additionally. The median dose for the whole-ventricle was 25.2 Gy (range: 18–30.6 Gy) and 36 Gy (range: 30–54 Gy) for the tumor bed boost. The median post-radiation therapy follow-up was 57.5 months. There were 3 recurrences (2 NGGCT and 1 germinoma that recurred as a NGGCT), with 1 death from the disease and the other 2 cases each successfully rescued with chemotherapy and craniospinal irradiation. The overall survival at 5 years was 95% and disease-free survival was 85%.


The results of this study suggest that the combined use of chemotherapy followed by whole ventricle irradiation with intensity-modulated radiation therapy is effective for CNS-GCTs, especially pure germinomas. Even being rescued with craniospinal irradiation, the NGGCT cases have markedly worse prognoses and should be more rigorously selected for localized treatment.

Klíčová slova:

Cancer chemotherapy – Cancer treatment – Central nervous system – Cerebrospinal fluid – Germ cells – Histology – Magnetic resonance imaging – Radiation therapy


1. Rickert C, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 2001;17(9):503–511. doi: 10.1007/s003810100496 11585322

2. Rosemberg S, Fujiwara D. Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution. Childs Nerv Syst 2005;21(11):940–944. doi: 10.1007/s00381-005-1181-x 16044344

3. Echevarría ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist 2008;13(6):690–699. doi: 10.1634/theoncologist.2008-0037 18586924

4. Poynter JN, Fonstad R, Tolar J, Spector LG, Ross JA. Incidence of intracranial germ cell tumors by race in the United States, 1992–2009: A potential link with autoimmune encephalitis? [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6–10; Washington. Cancer Re. 2013;73(8 Suppl):Abstract 2291. Available from: Accessed in 2016 (Sep 27).

5. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131(6):803–820. doi: 10.1007/s00401-016-1545-1 27157931

6. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 1997;86(3):446–455. doi: 10.3171/jns.1997.86.3.0446 9046301

7. Ogino H, Shibamoto Y, Takanaka T, Suzuki K, Ishihara S, Yamada T, et al. CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys 2005;62(3):803–808. doi: 10.1016/j.ijrobp.2004.10.026 15936563

8. Calaminus G, Kortmann R, Frappaz D. CNS GCT 96 protocol for intracranial localised and metastatic non-germinomatous germ cell tumors (NGGCT). [Special Issue: 43rd Congress of the International Society of Paediatric Oncology (SIOP) 2011, Auckland, New Zealand, 28th–30th October, 2011.] Pediatr Blood Cancer 2011;57(5):743–744. [abstract].

9. da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, et al. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. Pediatr Blood Cancer 2010;54(3):377–383. doi: 10.1002/pbc.22381 20063410

10. Eom KY, Kim IH, Park CI, Kim HJ, Kim JH, Kim K, et al. Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed. Int J Radiat Oncol Biol Phys 2008;71(3):667–671. doi: 10.1016/j.ijrobp.2008.01.061 18514777

11. Cappellano AM, Paiva P, Cavalheiro S, Dástoli P, Seixas MT, Silva NS. Treatment of intracranial germinoma: Experience of a Brazilian institution. Neuro Oncol 2012;14(Suppl 1):i49–55. [GC-18]. Available from: Accessed in 2019 (27 Nov).

12. Khatua S, Dhall G, O’Neil S, Jubran R, Villablanca JG, Marachelian A, et al. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer 2010;55(1):42–46. doi: 10.1002/pbc.22468 20222020

13. Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998;82(1):208–218. 9428499

14. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998;16(5):1723–1728. doi: 10.1200/JCO.1998.16.5.1723 9586884

15. Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys 2006;65(1):210–221. doi: 10.1016/j.ijrobp.2005.10.038 16472938

16. Pirzkall A, Carol M, Lohr F, Höss A, Wannenmacher M, Debus J. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys 2000;48(5):1371–1380. doi: 10.1016/s0360-3016(00)00772-0 11121636

17. Silber JH, Radcliffe J, Peckham V, Perilongo G, Kishnani P, Fridman M, et al. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 1992;10(9):1390–1396. doi: 10.1200/JCO.1992.10.9.1390 1517781

18. O’Neil S, Ji L, Buranahirun C, Azoff J, Dhall G, Khatua S, et al. Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation. Pediatr Blood Cancer 2011;57(4):669–673. doi: 10.1002/pbc.23146 21495164

19. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21(1):109–122. doi: 10.1016/0360-3016(91)90171-y 2032882

20. Cox JD; Stetz J; Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31(5):1341–1346. doi: 10.1016/0360-3016(95)00060-C 7713792

21. Shim KW, Park EK, Lee YH, Suh CO, Cho J, Choi JU, et al. Treatment strategy for intracranial primary pure germinoma. Childs Nerv Syst. 2013 Feb;29(2):239–248. doi: 10.1007/s00381-012-1902-x 22965772

22. Matsutani M; Japanese Pediatric Brain Tumor Study Group. Combined chemotherapy and radiation therapy for CNS germ cell tumors—the Japanese experience. J Neurooncol 2001;54(3):311–316. doi: 10.1023/a:1012743707883 11767296

23. Rogers SJ, Mosleh-Shirazi MA, Saran FH. Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol 2005;6(7):509–519. doi: 10.1016/S1470-2045(05)70245-X 15992700

24. Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garrè ML, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 2013;15(6):788–796. doi: 10.1093/neuonc/not019 23460321

25. Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, et al. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol 2017;19(12):1661–1672. doi: 10.1093/neuonc/nox122 29048505

26. De B, Cahlon O, Dunkel IJ, De Braganca KC, Khakoo Y, Gilheeney SW, et al. Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors. J Neurooncol 2017;134(2):349–356. doi: 10.1007/s11060-017-2532-7 28660318

27. Robertson PL, Jakacki R, Hukin J, Siffert J, Allen JC. Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study. J Neurooncol 2014;118(1):93–100. doi: 10.1007/s11060-013-1306-0 24700239

28. Bowzyk Al-Naeeb A, Murray M, Horan G. Current Management of Intracranial Germ Cell Tumours. Clin Oncol (R Coll Radiol) 2018;30(4):204–214.

29. Matsutani M. Treatment of intracranial Germ Cell Tumor in Japan: New Horizon of the Germ Cell Therapy. Seoul: The Korean Society for Pediatric Neuro-Oncology; 2013. p. 8.

30. Kim J, Park J. Understanding the Treatment Strategies of Intracranial Germ Cell Tumors: Focusing on Radiotherapy. J Korean Neurosurg Soc 2015;57(5):315–322. doi: 10.3340/jkns.2015.57.5.315 26113957

31. Cheng S, Kilday JP, Laperriere N, Janzen L, Drake J, Bouffet E, et al. Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation. J Neurooncol 2016;127(1):173–180. doi: 10.1007/s11060-015-2029-1 26744133

32. Cahlon O, Dunkel I, Gilheeney S, Khakoo Y, Souweidane M, De Braganca K, et al. Craniospinal radiation therapy may not be necessary for localized nongerminomatous germ cell tumors (NGGCT). International Journal of Radiation Oncology Biology Physics. 2014;90 (1 Supplement): S723–S724. [abstract 3303]. Available from: Accessed in 2019 (May 27).

33. Kenjo M, Yamasaki F, Takayasu T, Nosaka R, Murakami Y, Kimura T, et al. Results of sequential chemoradiotherapy for intracranial germinoma. Jpn J Radiol. 2015;33(6):336–43. doi: 10.1007/s11604-015-0424-3 25943790

34. Yang JC, Terezakis SA, Dunkel IJ, Gilheeney SW, Wolden SL. Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors. Pediatr Blood Cancer. 2016;63(4):646–51. doi: 10.1002/pbc.25867 26703370

35. Murray MJ, Bartels U, Nishikawa R. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol 2015;16(9):e470–e477. doi: 10.1016/S1470-2045(15)00244-2 26370356

36. Hu YW, Huang PI, Wong TT, Ho DM, Chang KP, Guo WY, et al. Salvage treatment for recurrent intracranial germinoma after reduced-volume radiotherapy: a single-institution experience and review of the literature. Int J Radiat Oncol Biol Phys 2012;84(3):639–647. doi: 10.1016/j.ijrobp.2011.12.052 22361082

37. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S20–7. doi: 10.1016/j.ijrobp.2009.02.091 20171513

38. Chen MJ, Santos Ada S, Sakuraba RK, Lopes CP, Gonçalves VD, Weltman E, et al. Intensity-modulated and 3D-conformal radiotherapy for whole-ventricular irradiation as compared with conventional whole-brain irradiation in the management of localized central nervous system germ cell tumors. Int J Radiat Oncol Biol Phys 2010;76(2):608–614. doi: 10.1016/j.ijrobp.2009.06.028 19879065

39. Ladra MM, MacDonald SM, Terezakis SA. Proton therapy for central nervous system tumors in children. Pediatr Blood Cancer 2018;65(7):e27046. doi: 10.1002/pbc.27046 29630784

40. St Clair WH, Adams JA, Bues M. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.Int J Radiat Oncol Biol Phys 2004;58(3):727–34. doi: 10.1016/S0360-3016(03)01574-8 14967427

41. Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 2016;17(3):287–98. doi: 10.1016/S1470-2045(15)00167-9 26830377

42. Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys 2014;90(2):354–61. doi: 10.1016/j.ijrobp.2014.05.051 25052561

43. Paganetti H. Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice? Int J Radiat Oncol Biol Phys 2015;91(5):892–4. doi: 10.1016/j.ijrobp.2014.11.021 25832682

44. Kahalley LS, Ris MD, Grosshans DR, Okcu MF, Paulino AC, Chintagumpala M, et al. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol 2016;34(10):1043–1049. doi: 10.1200/JCO.2015.62.1383 26811522

Článek vyšel v časopise


2019 Číslo 12
Nejčtenější tento týden